Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Hexarelin

Examorelin, HEX

Quick Stats
Studies 233
Trials 61
Score 1
2003 pubmed

Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.

Arnaldi. G G; Mancini. T T; Kola. B B; Appolloni. G G; Freddi. S S; Concettoni. C C; Bearzi. I I; Masini. A A; Boscaro. M M; Mantero. F F

Key Findings

  • The bronchial carcinoid tumor expressed ghrelin and both GHS‑R1a and GHS‑R1b receptors.
  • Hexarelin administration caused a measurable increase in ACTH release from the tumor in vivo.
  • This is the first documented case linking hexarelin to ACTH hyperresponsiveness in an ectopic ACTH‑secreting tumor.

Practical Outcomes

  • For most healthy biohackers, this case offers little direct guidance. It does suggest that hexarelin can affect ACTH pathways in rare pathological contexts, so individuals with unknown endocrine tumors should be cautious. No actionable dosing or performance protocol can be derived from this report.

Summary

A 56‑year‑old woman with a rare lung carcinoid tumor that secreted ACTH also had the hormone‑producing machinery for ghrelin and its receptors. When given hexarelin (a ghrelin‑like peptide), her tumor released even more ACTH, showing that hexarelin can directly stimulate ACTH production in certain abnormal cells.

Abstract

A 56-yr-old woman was referred with a diagnosis of Cushing's disease. Hypertension and severe hypokalemia were present and high urinary free cortisol/cortisone ratio was detected, raising a suspicion of an ectopic ACTH syndrome. Inferior petrosal sinus sampling, thoracic computed tomography, and octreotide scans were negative. Remission and relapse periods lasting 3-4 months were observed during the 3.5 yr of follow-up. Finally a thoracic computed tomography scan showed a basal paracardic nodule in the left lung. After surgery, a well-differentiated neuroendocrine tumor (typical bronchial carcinoid) was diagnosed, staining positively for ACTH. RT-PCR revealed expression of proopiomelanocortin, CRH receptor, and V3 vasopressin receptor. Somatostatin receptor type 1, 2, 3, and 5 mRNA was detected only in tumoral tissue. Interestingly, we observed the simultaneous presence of ghrelin and both GH secretagogue (GHS) receptors (1a and 1b) mRNA in tumoral tissue but not in the normal lung. This finding correlates with the in vivo ACTH hyperresponsiveness to hexarelin (a GHS). This is the first report of a cyclical ectopic ACTH-secreting tumor with an in vivo ACTH response to hexarelin coupled with the tumoral expression of ghrelin and GHS receptors. This finding might imply an autocrine/paracrine modulatory effect of ghrelin in bronchial ACTH-secreting tumors.

Study Information

Provider

pubmed

Year

2003

DOI

10.1210/jc.2003-030514